Jump to content

Recommended Posts

Posted

The packing of drugs into mitochondria for administration and delivery to the site of action in vivo could be efficient as it could avoid immune response being an endogenous nanoparticle and be membrane permeable with improved drug lifetime. Attachment of mAbs to the outer membrane may direct it to the desired cells/site of action. This method may be also possible for gene therapy.

 

Is this method feasible or at least a worthwhile topic of research?

Posted

Thanks for the correction, for some reason I associated mitochondria with nanoparticles. I was simply suggesting mitochondria as an alternative to exosomes.

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.